1. Home
  2. CNDT vs IVVD Comparison

CNDT vs IVVD Comparison

Compare CNDT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.55

Market Cap

235.7M

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$0.68

Market Cap

201.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
IVVD
Founded
2016
2020
Country
United States
United States
Employees
51000
122
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.7M
201.9M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
CNDT
IVVD
Price
$1.55
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.75
AVG Volume (30 Days)
1.1M
5.2M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
$3,042,000,000.00
$53,426,000.00
Revenue This Year
$2.01
$61.57
Revenue Next Year
$4.06
$41.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
110.47
52 Week Low
$1.15
$0.49
52 Week High
$2.98
$3.07

Technical Indicators

Market Signals
Indicator
CNDT
IVVD
Relative Strength Index (RSI) 53.58 32.04
Support Level $1.32 N/A
Resistance Level $1.61 $1.01
Average True Range (ATR) 0.09 0.07
MACD 0.02 -0.01
Stochastic Oscillator 57.86 1.81

Price Performance

Historical Comparison
CNDT
IVVD

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Share on Social Networks: